Overview
- Product nameAnti-BCMA antibodySee all BCMA primary antibodies ...
- DescriptionRabbit polyclonal to BCMA
- Tested applicationsICC/IF, IHC-P, WB more details
- Species reactivityReacts with: Human
- Immunogen
Synthetic peptide (Human).
- Positive controlHuman spleen tissue lysate, K562 or U937 whole cell lysates.
- General notesStable for one year.
Members in the TNF superfamily regulate immune responses and induce apoptosis. Two novel members in the TNF family were recently identified and designated BAFF/BLyS/TALL1/THANK/zTNF4 and April/TALL2, respectively. BAFF was characterized as a B cell activator since it induced B cell proliferation and immunoglobulin secretion. April regulates immunological and non immunological cell growth. Three receptors, BCMA (for B cell maturation protein), TACI, and BAFFR, for BAFF were recently identified. BCMA, like TACI, binds BAFF and April. BAFF and its receptors induce B cell development and survival, activate NF-kappaB and c-jun N-terminal kinase, and are involved in B cell associated autoimmune diseases.
Properties
- FormLiquid
- Storage instructionsStore at +4°C.
- Storage bufferPreservative: 0.02% Sodium Azide
Constituents: PBS -
Concentration information loading... - PurityImmunogen affinity purified
- Primary antibody notes Members in the TNF superfamily regulate immune responses and induce apoptosis. Two novel members in the TNF family were recently identified and designated BAFF/BLyS/TALL1/THANK/zTNF4 and April/TALL2, respectively. BAFF was characterized as a B cell activator since it induced B cell proliferation and immunoglobulin secretion. April regulates immunological and non immunological cell growth. Three receptors, BCMA (for B cell maturation protein), TACI, and BAFFR, for BAFF were recently identified. BCMA, like TACI, binds BAFF and April. BAFF and its receptors induce B cell development and survival, activate NF-kappaB and c-jun N-terminal kinase, and are involved in B cell associated autoimmune diseases.
- Clonality Polyclonal
- IsotypeIgG
- Research Areas
Applications
Our Abpromise guarantee covers the use of ab5972 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| Application | Notes |
|---|---|
| ICC/IF | ICC/IF: Use a concentration of 20 µg/ml. |
| IHC-P | IHC-P: Use a concentration of 10 µg/ml. |
| WB | WB: Use a concentration of 2 - 5 µg/ml. Predicted molecular weight: 20 kDa.Can be blocked with BCMA peptide (human) (ab6087). |
Target
- FunctionReceptor for TNFSF13B/BLyS/BAFF and TNFSF13/APRIL. Promotes B-cell survival and plays a role in the regulation of humoral immunity. Activates NF-kappa-B and JNK.
- Tissue specificityExpressed in mature B-cells, but not in T-cells or monocytes.
- Involvement in diseaseNote=A chromosomal aberration involving TNFRSF17 is found in a form of T-cell acute lymphoblastic leukemia (T-ALL). Translocation t(4;16)(q26;p13) with IL2.
- Sequence similaritiesContains 1 TNFR-Cys repeat.
- Cellular localizationCell membrane. Endomembrane system. Perinuclear Golgi-like structures.
-
Database links
- Entrez Gene: 608 Human
- Omim: 109545 Human
- SwissProt: Q02223 Human
- Unigene: 2556 Human
Target information above from: UniProt accession
Q02223
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010)
.
-
Alternative names
- B cell maturation antigen antibodyB Cell Maturation Factor antibodyB cell maturation protein antibody
- B-cell maturation protein antibodyBCM antibodyBCMA antibodyCD269 antibodyCD269 antigen antibodyTNFRSF17 antibodyTNR17_HUMAN antibodyTumor Necrosis Factor Receptor Member 17 antibodyTumor necrosis factor receptor superfamily member 17 antibody
see all
Anti-BCMA antibody images
-
Predicted band size : 20 kDa
Western blot analysis of BCMA in human spleen (A) tissue lysate, K562 (B), and U937 (C) cell lysates with ab5972 at 5 µg/ml. -
ab5972 at 10µg/ml staining BCMA in human spleen cells by IHC
-
Immunofluorescence of BCMA in Human Spleen cells using ab5972 at 10 ug/ml.
References for Anti-BCMA antibody (ab5972)
This product has been referenced in:
- Brady G et al. Downregulation of RUNX1 by RUNX3 requires the RUNX3 VWRPY sequence and is essential for Epstein-Barr virus-driven B-cell proliferation. J Virol 83:6909-16 (2009). Read more (PubMed: 19403666) »


